US Broker Ratings

Replimune Group, Inc. (REPL) Stock Analysis: Exploring a 54.76% Potential Upside in Biotechnology

Replimune Group, Inc. (NASDAQ: REPL), a promising player in the biotechnology sector, is attracting attention from investors with its innovative approach to cancer treatment. Based in..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Exploring an 83.72% Potential Upside

Stoke Therapeutics, Inc. (NASDAQ: STOK) stands at an intriguing crossroads for investors with its innovative approach to tackling severe genetic diseases. The company’s focus on upregulating..

Verastem, Inc. (VSTM) Stock Analysis: Exploring an 88% Potential Upside in the Biotech Sector

Verastem, Inc. (NASDAQ: VSTM) is attracting significant attention among investors in the biotechnology sector, driven primarily by its robust potential upside of 88.03%, as suggested by..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring an 80% Potential Upside in the Cannabis Market

Tilray Brands, Inc. (NASDAQ: TLRY) has become a focal point for investors eyeing the burgeoning cannabis industry. With its recent price of $4.07 and a market..

SIGA Technologies Inc. (SIGA) Stock Analysis: Unveiling the Potential in the Healthcare Sector

SIGA Technologies Inc. (NASDAQ: SIGA), a key player in the healthcare sector, specializes in the development of antiviral drugs, most notably TPOXX, which targets human smallpox..

MeiraGTx Holdings plc (MGTX) Stock Analysis: A 151% Potential Upside in the Biotechnology Sphere

MeiraGTx Holdings plc (NASDAQ: MGTX), a clinical-stage genetic medicines company, is making waves in the biotechnology sector with its innovative approach to treating serious diseases. With..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Exploring a Potential 301% Upside in the Biotech Space

Sionna Therapeutics, Inc. (NASDAQ: SION), a clinical-stage biopharmaceutical company, has been drawing attention in the biotech sector with its promising pipeline for treating cystic fibrosis (CF)...

Autolus Therapeutics (AUTL) Stock Analysis: Unveiling a 356% Potential Upside in the Biotech Arena

Autolus Therapeutics plc (NASDAQ: AUTL), a promising player in the biotechnology sector, is capturing investor attention with its substantial growth potential. Headquartered in London, this clinical-stage..

Akso Health Group (AHG) Stock Analysis: Navigating the Challenges in China’s Medical Distribution Sector

Akso Health Group (NASDAQ: AHG), headquartered in Qingdao, China, operates within the healthcare sector, specifically focusing on medical distribution. Despite its diversified portfolio of products and..

Geron Corporation (GERN) Stock Analysis: A Biotech Gem with 237% Upside Potential

Geron Corporation (NASDAQ: GERN), a biopharmaceutical company entrenched in the cutting-edge field of oncology therapeutics, is capturing the attention of investors with its robust pipeline and..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Potential 301% Upside with Strong Buy Ratings

Niagen Bioscience, Inc. (NAGE), a company nestled within the Consumer Defensive sector, is capturing investor attention with its substantial potential upside and robust analyst endorsements. Operating..

Definitive Healthcare Corp. (DH) Stock Analysis: Unpacking the 88% Potential Upside

Definitive Healthcare Corp. (NASDAQ: DH) stands as a dynamic player in the healthcare sector, specifically within the health information services industry. The company, headquartered in Framingham,..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating Challenges with a Potential 9.59% Upside

Community Health Systems, Inc. (NYSE: CYH), headquartered in Franklin, Tennessee, is a prominent player in the healthcare sector, specifically within the medical care facilities industry. With..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a Potential 194.66% Upside in the Biotech Sphere

Kura Oncology, Inc. (NASDAQ: KURA), a prominent player in the biotechnology sector, is drawing attention from investors on account of its promising pipeline and potential for..

Arvinas, Inc. (ARVN) Stock Analysis: Exploring an 78.80% Upside Potential in the Biotech Sector

Arvinas, Inc. (ARVN), a promising player in the biotechnology industry, has been making waves with its innovative approach to drug development. As a clinical-stage biotech firm,..

Valneva SE (VALN) Stock Analysis: Is a 96.95% Upside Within Reach for This Biotech Pioneer?

Valneva SE (VALN), a France-based biotechnology company specializing in vaccines, stands at a crossroads that could spell a significant opportunity for investors. With a market capitalization..

Inventiva S.A. (IVA) Stock Analysis: Exploring the Biotech’s 356% Upside Potential and Strong Buy Ratings

Inventiva S.A. (IVA), a clinical-stage biopharmaceutical company listed on the American Depository market, is making waves in the healthcare sector, particularly within the biotechnology industry. Headquartered..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Challenges with Strategic Innovation

For investors keeping a close eye on the healthcare sector, Myriad Genetics, Inc. (NASDAQ: MYGN) presents a complex yet intriguing picture. With a market capitalization of..

AtaiBeckley Inc. (ATAI) Stock Analysis: A Healthcare Innovator with Potential 10.43% Upside

AtaiBeckley Inc. (ATAI) stands at the forefront of the biotechnology industry, primarily focused on developing groundbreaking treatments for mental health conditions. Operating as a subsidiary of..

ArriVent BioPharma, Inc. (AVBP) Investor Outlook: Exploring a 48.50% Potential Upside in the Biotechnology Sector

ArriVent BioPharma, Inc. (NASDAQ: AVBP), a burgeoning player in the biotechnology sector, has caught the attention of investors with its promising pipeline and substantial potential upside..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds